Multi-link Vision and MiniVision stent registry in Asian patients with coronary artery disease: A prospective, multi-center study

Chinese Medical Journal

Volumn 120, Issue 12, 2007, Pages 1093-1096

  Xu, Yae Wei ^a   Wei, Yi Dong ^b   Tang, Kai ^b   Chen, Yan Qing ^b   Li, Wei Ming ^b   Yu, Xue Jing ^b   Qin, Yong Wen ^c   Qi, Gou Xian ^d   Qu, Peng ^e   Hou, Yu Qing ^f   Jain, Ashok ^g   Grant, Parvez ^h   Ramesh, Gudapati ⁱ   Ramesh, Basavappa ^j   Piamsomboon, Chumpol ^k   Kuanprasert, Srun ^l   Gwon, Hyeon Cheol ^m   Cho, Yoon Haeng ⁿ   Kamar, Haizal Haroon ^o   Huang, Cong Xin ^a  

^a WUHAN UNIVERSITY   (China)

^b TONGJI UNIVERSITY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d CHINA MEDICAL UNIVERSITY   (China)

^e DALIAN MEDICAL UNIVERSITY   (China)

^f FIRST MILITARY MEDICAL UNIVERSITY   (China)

^g SDMH   (India)

^h Ruby Hall Clinic ^*  (India)

ⁱ Ushamullapudi Cardiac Center   (India)

^j SRI JAYADEVA INSTITUTE OF CARDIOVASCULAR SCIENCES AND RESEARCH   (India)

^k PHRAMONGKUTKLAO HOSPITAL   (Thailand)

^l CHIANG MAI UNIVERSITY   (Thailand)

^m Samsung Medical Center   (South Korea)

ⁿ Wonju Severance Christian Hospital   (South Korea)

^o UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

more..

Author keywords

Asian population; Bare metal stents; Registry study

Indexed keywords

ADULT; AGED; ANGINA PECTORIS; ARTICLE; ASIAN; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY STENT; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PROSPECTIVE STUDY; REGISTER; TREATMENT OUTCOME;

EID: 34547533727     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200706020-00012     Document Type: Article

References (21)

1. Cutlip DE. Drug-eluting stent era: will we improve 5-year outcomes? Coron Artery Dis 2006; 17: 681-684.
2. Pinto DS, Ryan J, Cohen DJ. Drug-eluting stents for stent thrombosis elevation acute myocardial infarction: do we need randomized trials? Coron Artery Dis 2006; 17: 667-671.
3. Holmes DR Jr, Moses JW, Schofer J, Morice MC, Schampaert E, Leon MB. Cause of death with bare metal and sirolimus-eluting stents. Eur Heart J 2006; 27: 2815-2822.
4. Wernick MH, Jeremias A, Carrozza JP. Drug-eluting stents and stent thrombosis: a cause for concern? Coron Artery Dis 2006; 17: 661-665.
5. Garcia-Garcia HM, Vaina S, Tsuchida K, Serruys PW. Drug-eluting stents. Arch Cardiol Mex 2006; 76: 297-319.
6. Angiolillo DJ, Sabaté M, Alfonso F, Macaya C. "Candy wrapper" effect after drug-eluting stent implantation: deja vu or stumbling over the same stone again? Cathet Cardiovasc Interv 2004; 61: 387-391.
7. Raja SG, Dreyfus GD. Efficacy and safety of drug-eluting stents: current best available evidence. J Card Surg 2006; 21: 605-612.
8. De Luca G, Suryapranata H, van't Hof AW, Ottervanger JP, Hoorntje JC, Dambrink JH, et al. Comparison between stenting and balloon angioplasty in patients undergoing primary angioplasty of small coronary vessels. Am Heart J 2006; 152: 915-920.
9. Roussanov O, Estacio G, Capuno M, Archuleta L, Hill J, Jarmukli NF. Nonemergent percutaneous coronary interventions in a veterans affairs medical center without onsite cardiac surgery. Am Heart J 2006; 152: 909-913.
10. Zavalloni D, Belli G, Rossi ML, Scatturin M, Morenghi E, Catalano G, et al. Comparison between drug-eluting stents and beta-radiation for the treatment of diffuse in-stent restenosis: clinical and angiographic outcomes. Am Heart J 2006; 152: 908.e1-e7.
11. Han SH, Ahn TH, Kang WC, Oh KJ, Chung WJ, Shin MS, et al. The favorable clinical and angiographic outcomes of a high-dose dexamethasone-eluting stent: randomized controlled prospective study. Am Heart J 2006; 152: 887.e1-e7.
12. Ben-Gal Y, Moshkovitz Y, Nesher N, Uretzky G, Braunstein R, Hendler A, et al. Drug-eluting stents versus coronary artery bypass grafting in patients with diabetes mellitus. Ann Thorac Surg 2006; 82: 1692-1697.
13. Williams DO, Abbott JD, Kip KE; DEScover Investigators. Outcomes of 6906 patients undergoing percutaneous coronary intervention in the era of drug-eluting stents: report of the DEScover Registry. Circulation 2006; 114: 2154-2162.
14. Aggarwal A. Inflammatory response to drug-eluting stent placement. Am J Cardiol 2006; 98: 1299.
15. Compton PA, Zankar AA, Adesanya AO, Banerjee S, Brilakis ES. Risk of noncardiac surgery after coronary drug-eluting stent implantation. Am J Cardiol 2006; 98: 1212-1213.
16. Daemen J, Serruys PW. Optimal revascularization strategies for multivessel coronary artery disease. Curr Opin Cardiol 2006; 21: 595-601.
17. Biondi-Zoccai GG, Lotrionte M, Agostoni P, Abbate A, Fusaro M, Burzotta F, et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease. Eur Heart J 2006; 27: 2667-2674.
18. Huang LY, Yang MC. Hemocompatibility of layer-by-layer hyaluronic acid/ heparin nanostructure coating on stainless steel for cardiovascular stents and its use for drug delivery. J Nanosci Nanotechnol 2006; 6: 3163-3170.
19. Pan CJ, Tang JJ, Weng YJ, Wang J, Huang N. Preparation, characterization and anticoagulation of curcumin-eluting controlled biodegradable coating stents. J Control Release 2006; 116: 42-49.
20. Commeau P, Barragan P, Roquebert PO. Sirolimus for below the knee lesions: mid-term results of SiroBTK study. Catheter Cardiovasc Interv 2006; 68: 793-798.
21. Pache J, Kastrati A, Mehilli J, Schühlen H, Dotzer F, Hausleiter J, et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. JACC 2003; 41: 1283-1288.